Sang‐Young Ryu - Concepedia

Author

Sang‐Young Ryu

Korea Institute of Radiological and Medical Sciences

Also Known As

Sang-Young Ryu, Sang‐Young Ryu

Publications

656

Citations

H-Index

Concepts

All Affiliations

Korea Institute of Radiological and Medical Sciences National Cancer Center Asan Medical Center Seoul National University Hospital Seoul National University

About

Sang‐Young Ryu is an author at Korea Institute of Radiological and Medical Sciences specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	301
2	Obstetrics	6	6	290
3	Public Health	3	3	210
4	Cell Biology	1	1	11
5	Immunology	1	1	11

Sang‐Young Ryu

Publications

605

Citations

H-Index

Page 1

	Year	Citations
Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. Sang‐Young Ryu, Moon‐Hong Kim, Suck-Chul Choi, PubMed	2003	150
Randomized Clinical Trial of Weekly vs. Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Locally Advanced Cervical Cancer Sang‐Young Ryu, Won-Moo Lee, Kidong Kim, International Journal of Radiation OncologyBiologyPhysics Randomized Clinical TrialCervical Cancer ManagementCervical CancerRadiation TherapyMedicine	2011	80
Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer Tae Hun Kim, Moon‐Hong Kim, Beob‐Jong Kim, International Journal of Radiation OncologyBiologyPhysics Cervical Cancer ManagementCervical CancerMedicineCancer RecurrenceCancer Management	2017	67
Is Adjuvant Chemoradiotherapy Overtreatment in Cervical Cancer Patients With Intermediate Risk Factors? Sang‐Young Ryu, Sang-Il Park, Byung‐Ho Nam, International Journal of Radiation OncologyBiologyPhysics Cervical Cancer ManagementIntermediate Risk FactorsCervical CancerRadiation TherapyMedicine	2010	63
Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study Sokbom Kang, Joo‐Hyun Nam, Duk‐Soo Bae, Cancer	2016	55
Final overall survival results from SOLO3: Phase III trial assessing olaparib monotherapy versus non-platinum chemotherapy in heavily pretreated patients with germline BRCA1 - and/or BRCA2-mutated platinum-sensitive relapsed ovarian cancer (026) Richard T. Penson, Ricardo Villalobos-Valencia, Nicoletta Colombo, Gynecologic Oncology Olaparib MonotherapyMedicineCancer ManagementPhase Iii TrialGynecology	2022	34
Analysis of immune cell populations and cytokine profiles in murine splenocytes exposed to whole-body low-dose irradiation Kyung‐Hee Song, Mi‐Hyoung Kim, Seong-Mook Kang, International Journal of Radiation Biology	2015	30
Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial Shoji Nagao, Keiichi Fujiwara, Kouji Yamamoto, NEJM Evidence Intraperitoneal ChemotherapyEpithelial Ovarian CancerMedicineCancer ManagementGynecology	2023	24
Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer Hyo‐Pyo Lee, Sang‐Soo Seo, Sang‐Young Ryu, Gynecologic Oncology Phase Ii EvaluationOncologyMedicineGynecologyCamptothecin Analog	2008	22
Detection of Recurrence by <sup>18</sup>F-FDG PET in Patients with Endometrial Cancer Showing No Evidence of Disease Sang‐Young Ryu, Kidong Kim, Younha Kim, Journal of Korean Medical Science	2010	22

Page 1